CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MyoPax is a company focused on developing innovative stem cell therapies for muscle wasting disorders. They utilize a proprietary technology to create highly regenerative muscle stem cells, aiming to provide effective treatments for conditions that currently have no cure.
MyoPax is a women founded company with locations in Germany and in Denmark.
Myopax uses a proprietary, patented, first-in-class stem cell technology to become the leading engineering platform for the treatment of skeletal muscle wasting disorders.
In Europe alone, more than 20M people are affected by the devastating consequences of muscle wasting.
Only palliative care is available.We developed a method to produce pure and highly regenerative muscle stem cell populations (PHSats, Primary Human Sa…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
